MX2015007082A - Métodos de administración de composiciones que comprenden ácido docosapentanoico. - Google Patents
Métodos de administración de composiciones que comprenden ácido docosapentanoico.Info
- Publication number
- MX2015007082A MX2015007082A MX2015007082A MX2015007082A MX2015007082A MX 2015007082 A MX2015007082 A MX 2015007082A MX 2015007082 A MX2015007082 A MX 2015007082A MX 2015007082 A MX2015007082 A MX 2015007082A MX 2015007082 A MX2015007082 A MX 2015007082A
- Authority
- MX
- Mexico
- Prior art keywords
- administration
- methods
- compositions
- docosapentanoic acid
- cholesterol
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 6
- 235000012000 cholesterol Nutrition 0.000 abstract 3
- 102000007330 LDL Lipoproteins Human genes 0.000 abstract 2
- 108010007622 LDL Lipoproteins Proteins 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 abstract 1
- 235000021294 Docosapentaenoic acid Nutrition 0.000 abstract 1
- 235000021588 free fatty acids Nutrition 0.000 abstract 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract 1
- 150000003626 triacylglycerols Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B20/00—Preservation of edible oils or fats
- A23B20/30—Preservation of other edible oils or fats, e.g. shortenings or cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- C11B5/0007—Organic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Botany (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261734331P | 2012-12-06 | 2012-12-06 | |
| US201361780948P | 2013-03-13 | 2013-03-13 | |
| PCT/US2013/073714 WO2014089511A2 (en) | 2012-12-06 | 2013-12-06 | Methods of administering compositions comprising docosapentaenoic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015007082A true MX2015007082A (es) | 2016-01-12 |
Family
ID=50884050
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015007082A MX2015007082A (es) | 2012-12-06 | 2013-12-06 | Métodos de administración de composiciones que comprenden ácido docosapentanoico. |
| MX2015007085A MX2015007085A (es) | 2012-12-06 | 2013-12-06 | Composiciones de acido omega-3 pentanoico y metodos de uso. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015007085A MX2015007085A (es) | 2012-12-06 | 2013-12-06 | Composiciones de acido omega-3 pentanoico y metodos de uso. |
Country Status (9)
| Country | Link |
|---|---|
| EP (3) | EP2928462A4 (OSRAM) |
| JP (4) | JP6881893B2 (OSRAM) |
| KR (3) | KR20210059779A (OSRAM) |
| CN (4) | CN112107570A (OSRAM) |
| AU (7) | AU2013354979A1 (OSRAM) |
| CA (2) | CA2894366A1 (OSRAM) |
| IN (2) | IN2015MU01505A (OSRAM) |
| MX (2) | MX2015007082A (OSRAM) |
| WO (2) | WO2014089511A2 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101568665B1 (ko) | 2015-07-21 | 2015-11-12 | 디와이오토 주식회사 | 모터의 맥동 전류를 증가시키는 브러시 구조 |
| CN109313202A (zh) * | 2016-06-28 | 2019-02-05 | 雀巢产品技术援助有限公司 | 血脑屏障功能障碍的生物标志物 |
| JP2018168139A (ja) * | 2016-10-21 | 2018-11-01 | マルハニチロ株式会社 | ｎ−３系不飽和脂肪酸を含む中性脂肪値の低減または上昇抑制用の組成物、並びに該組成物の製造におけるｎ−３系不飽和脂肪酸の使用 |
| JP7099821B2 (ja) * | 2017-12-20 | 2022-07-12 | ポッカサッポロフード＆ビバレッジ株式会社 | Ｐｃｓｋ９阻害剤及びコレステロール代謝改善用食品組成物 |
| EP3586640A1 (en) | 2018-06-21 | 2020-01-01 | Nuseed Pty Ltd | Dha enriched polyunsaturated fatty acid compositions |
| EP3586642A1 (en) | 2018-06-21 | 2020-01-01 | Nuseed Pty Ltd | Ala enriched polyunsaturated fatty acid compositions |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| GB9901809D0 (en) * | 1999-01-27 | 1999-03-17 | Scarista Limited | Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes |
| GB0016045D0 (en) | 2000-06-29 | 2000-08-23 | Laxdale Limited | Therapeutic combinations of fatty acids |
| JP2002125618A (ja) * | 2000-10-30 | 2002-05-08 | Katsuyuki Wakatsuki | 健康食品 |
| EP1714564A1 (en) * | 2005-04-21 | 2006-10-25 | N.V. Nutricia | Method for treatment and prevention of respiratory insufficiency |
| WO2007058523A1 (en) | 2005-11-17 | 2007-05-24 | N.V. Nutricia | Composition with docosapentaenoic acid |
| NZ573719A (en) * | 2006-07-05 | 2011-08-26 | Photonz Corp Ltd | Production of ultrapure eicosapentaenoic acid and polar lipids from largely heterotrophic culture of nitzschia laevis |
| KR100684642B1 (ko) * | 2006-09-14 | 2007-02-22 | 주식회사 일신웰스 | 어유 유래 글리세라이드 유지 조성물 및 이의 제조방법 |
| AU2010222648B2 (en) * | 2009-03-09 | 2016-07-07 | Pronova Biopharma Norge As | Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof |
| US20110071090A1 (en) * | 2009-03-11 | 2011-03-24 | Stable Solutions Llc | Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle |
| US8241672B2 (en) * | 2009-03-11 | 2012-08-14 | Stable Solutions Llc | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| SMT201800047T1 (it) * | 2009-04-29 | 2018-03-08 | Amarin Pharmaceuticals Ie Ltd | Composizione farmaceutica stabile e metodi di utilizzo della stessa |
| KR102012111B1 (ko) * | 2009-06-15 | 2019-08-19 | 아마린 파마, 인크. | 병용 스타틴 요법을 받는 대상체에서 ｌｄｌ－ｃ 수준을 상승시키지 않으면서 트리글리세리드를 저하시키기 위한 조성물 및 방법 |
| CA2827555A1 (en) * | 2011-02-16 | 2012-08-23 | Pivotal Therapeutics, Inc. | Cholesterol absorption inhibitor (azetidinone) and omega 3 fatty acids (epa, dha, dpa) for the reduction of cholesterol and for the reduction of cardiovascular events |
| JP2014505732A (ja) * | 2011-02-16 | 2014-03-06 | ピヴォタル セラピューティクス インコーポレイテッド | 心血管疾患において用いるための、スタチンおよびω３脂肪酸（ＥＰＡ、ＤＨＡおよびＤＰＡ） |
| AU2013277441B2 (en) * | 2012-06-17 | 2017-07-06 | Matinas Biopharma, Inc. | Omega-3 pentaenoic acid compositions and methods of use |
-
2013
- 2013-12-06 KR KR1020217013255A patent/KR20210059779A/ko not_active Abandoned
- 2013-12-06 CA CA2894366A patent/CA2894366A1/en not_active Abandoned
- 2013-12-06 EP EP13861305.4A patent/EP2928462A4/en not_active Withdrawn
- 2013-12-06 JP JP2015545894A patent/JP6881893B2/ja not_active Expired - Fee Related
- 2013-12-06 AU AU2013354979A patent/AU2013354979A1/en not_active Abandoned
- 2013-12-06 WO PCT/US2013/073714 patent/WO2014089511A2/en not_active Ceased
- 2013-12-06 CN CN202010984870.2A patent/CN112107570A/zh active Pending
- 2013-12-06 EP EP21170003.4A patent/EP3888646A1/en not_active Withdrawn
- 2013-12-06 MX MX2015007082A patent/MX2015007082A/es unknown
- 2013-12-06 MX MX2015007085A patent/MX2015007085A/es unknown
- 2013-12-06 WO PCT/US2013/073701 patent/WO2014089501A1/en not_active Ceased
- 2013-12-06 KR KR1020157017202A patent/KR20150103009A/ko not_active Ceased
- 2013-12-06 JP JP2015545896A patent/JP2016501249A/ja active Pending
- 2013-12-06 CA CA2894183A patent/CA2894183A1/en not_active Abandoned
- 2013-12-06 CN CN201380063980.3A patent/CN104937103A/zh active Pending
- 2013-12-06 EP EP13861394.8A patent/EP2929041A4/en not_active Withdrawn
- 2013-12-06 AU AU2013354969A patent/AU2013354969A1/en not_active Abandoned
- 2013-12-06 CN CN201380064003.5A patent/CN104902888A/zh active Pending
- 2013-12-06 KR KR1020157016331A patent/KR20150103671A/ko not_active Ceased
- 2013-12-06 CN CN202110585483.6A patent/CN113274378A/zh active Pending
-
2015
- 2015-06-10 IN IN1505MU2015 patent/IN2015MU01505A/xx unknown
- 2015-06-10 IN IN5009DE2015 patent/IN2015DE05009A/xx unknown
-
2017
- 2017-09-22 AU AU2017232203A patent/AU2017232203A1/en not_active Abandoned
-
2018
- 2018-09-12 AU AU2018229440A patent/AU2018229440A1/en not_active Abandoned
-
2019
- 2019-06-20 JP JP2019114492A patent/JP2019172697A/ja active Pending
- 2019-08-14 AU AU2019216634A patent/AU2019216634A1/en not_active Abandoned
-
2020
- 2020-06-03 AU AU2020203658A patent/AU2020203658A1/en not_active Abandoned
-
2021
- 2021-03-24 AU AU2021201865A patent/AU2021201865A1/en not_active Abandoned
- 2021-05-19 JP JP2021084578A patent/JP2021120407A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP6881893B2 (ja) | 2021-06-02 |
| AU2017232203A1 (en) | 2017-10-12 |
| AU2019216634A1 (en) | 2019-09-05 |
| JP2019172697A (ja) | 2019-10-10 |
| KR20150103671A (ko) | 2015-09-11 |
| AU2013354979A1 (en) | 2015-06-11 |
| AU2020203658A1 (en) | 2020-06-25 |
| AU2021201865A1 (en) | 2021-04-22 |
| EP2928462A2 (en) | 2015-10-14 |
| IN2015DE05009A (OSRAM) | 2015-12-18 |
| CN113274378A (zh) | 2021-08-20 |
| JP2016501249A (ja) | 2016-01-18 |
| CN112107570A (zh) | 2020-12-22 |
| EP2929041A4 (en) | 2016-06-08 |
| KR20210059779A (ko) | 2021-05-25 |
| WO2014089511A2 (en) | 2014-06-12 |
| AU2018229440A1 (en) | 2018-10-04 |
| MX2015007085A (es) | 2016-01-12 |
| EP3888646A1 (en) | 2021-10-06 |
| CN104902888A (zh) | 2015-09-09 |
| EP2929041A1 (en) | 2015-10-14 |
| WO2014089511A3 (en) | 2014-07-31 |
| CA2894183A1 (en) | 2014-06-12 |
| CN104937103A (zh) | 2015-09-23 |
| CA2894366A1 (en) | 2014-06-12 |
| WO2014089501A1 (en) | 2014-06-12 |
| JP2021120407A (ja) | 2021-08-19 |
| IN2015MU01505A (OSRAM) | 2016-05-27 |
| EP2928462A4 (en) | 2016-06-01 |
| KR20150103009A (ko) | 2015-09-09 |
| JP2016501248A (ja) | 2016-01-18 |
| AU2013354969A1 (en) | 2015-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX372724B (es) | Formulaciones de acido eicosapentaenoico (epa). | |
| CL2019003105A1 (es) | Lípidos extraídos de plantas que comprenden ácidos grasos poliinsaturados de cadena larga. (divisional solicitud 201601560) | |
| EA201400152A1 (ru) | Микроорганизмы, продуцирующие эйкозапентаеновую кислоту, композиции, содержащие жирные кислоты, и способы их получения и применения | |
| HK1206248A1 (en) | Compositions of statins and omega-3 fatty acids | |
| MY165048A (en) | Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form | |
| MX2015007082A (es) | Métodos de administración de composiciones que comprenden ácido docosapentanoico. | |
| IN2014MN01673A (OSRAM) | ||
| PH12015501853A1 (en) | Nutritional compositions containing structured fat globules and uses thereof | |
| UY35537A (es) | Compuestos de amida sustituida | |
| EA201590026A1 (ru) | Выработка длинноцепочечных полиненасыщенных жирных кислот в растительных клетках | |
| NZ747847A (en) | Lipid compositions | |
| BR112014013593A2 (pt) | retenção de dha durante o processamento de óleo de canola | |
| MX374738B (es) | Aceite oxidativamente estable que contiene acidos grasos poliinsaturados. | |
| WO2012119781A3 (en) | Novel lipids, phospholipids, phospholipid and lipid compositions and their use | |
| BR112014009333A2 (pt) | processo para produzir um éster de ácido graxo epoxidizado a partir de uma gordura ou óleo natural epoxidizado | |
| UY36346A (es) | Compuestos de amida sustituida | |
| CY1117590T1 (el) | Μεθοδος για βιομηχανικη κατασκευη βιολογικων καυσιμων | |
| MX347400B (es) | Vacuna de aplicacion nasal contra el desarrollo de la enfermedad aterosclerotica y el higado graso. | |
| EA201692398A1 (ru) | Гомогенная композиция для перорального введения, содержащая омега-3 полиненасыщенные жирные кислоты и ресвератрол | |
| AR116761A2 (es) | Lípido que comprende ácidos grasos poliinsaturados de cadena larga | |
| CL2013002237A1 (es) | Arqueas que comprende lipidos etéricos insaturados; composicion lipidica obtenida de las mismas; metodo para obtener lipidos etericos. | |
| BR112019000462A2 (pt) | método para isolar lipídios de células contendo lipídio | |
| BR112019000435A2 (pt) | método para separar lipídios de uma biomassa contendo lipídios lisados | |
| Momchilova et al. | Influence of Xylooligosaccharide Intake on Liver Plasma Membrane Lipids in Rats | |
| CR20110015A (es) | Salicilatos acetilados con acidos grasos y sus usos |